Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Memorial Sloan Kettering Cancer Center
Age
30–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients (\> 30 years of age) at the time of the initial study visit.
Patients displaying a phenotype that consists of ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter. These patients have "atypical mole syndrome", which is a high-risk nevus phenotype and the target patient population in this study.
Patients with at least three clinically stable nevi between 5 and 20 mm in diameter.
Patients (or LAR) who are able to provide informed consent.
Patients with previous total body photography images taken at least 3 years prior
You may not be if
Patients without at least three clinically stable nevi between 5 and 20 mm in diameter.
Patients with any electronic implantable devices.
Patients who are pregnant (verbally confirmed with the participant).
Clareo Health | Study of the Nevisense Device to Assess Atypical Skin Lesions
